PHILADELPHIA — Ethos Cannabis partnered with Thomas Jefferson University to host the Pennsylvania Medical Marijuana Education & Research Summit on Friday, September 5, 2025, at Jefferson’s Alumni Hall Atrium from 8 am to 3:30 pm ET.
With more than 425,000 registered medical marijuana patients and a growing push toward adult-use legalization, Pennsylvania is at a pivotal moment in its cannabis evolution. Positioned as one of the nation’s most established medical-only cannabis markets, the Commonwealth now faces a unique opportunity to set the national standard for evidence-based cannabis policy, clinical research, and patient-first care.
To drive this conversation forward, the Pennsylvania Medical Marijuana Education & Research Summit aims to bridge the gap between public health, science, and policy, bringing together policy experts, researchers, clinicians, regulators, and industry experts to discuss how cannabis can safely and effectively meet the evolving needs of Pennsylvania’s patients and communities.
The summit will feature expert panels, educational sessions, and networking focused on the future of cannabis science and patient care. The summit will feature a keynote talk from Meghna Patel, Deputy Secretary of Policy and Planning at the Office of Governor Josh Shapiro, and talks from the Philadelphia Department of Public Health, Cannabis Control Commission, Drexel University, Thomas Jefferson University, Ethos Cannabis, and more.
Panels include:
- Keystone Shift – The Opioid Epidemic and the Role of Cannabis in Harm Reduction
- Moderator: Allison Herens (Philadelphia Department of Public Health)
Panelists:
- Steve Hoffman, Former Chair, MA Cannabis Control Commission
- Dr. Stephen Lankenau, Professor and Director of the Medical Cannabis Research Center, Drexel University
- Dr. Bill McLay, Lead Medical Professional, Ethos Cannabis
- Potency, Policy, and Public Health – Rethinking THC Limits
- Moderator: Greg Garber, PharmD, Thomas Jefferson University
Panelists:
- Emily Hajjar, PharmD, Jefferson College of Pharmacy
- Patrick LaRose, VP of Production, Ethos Cannabis
- Mallory Paul, VP of Commercial Development, ACT Labs
“As a physician and researcher, I’ve seen firsthand how important it is to have evidence-based conversations around cannabis,” said Dr. Brooke Worster, Chief Medical Officer at Ethos Cannabis and Medical Director at Thomas Jefferson University. “Our goal is to foster real-world understanding of how cannabis can complement traditional care, especially as we face overlapping public health crises like opioid misuse and chronic pain.”
About Ethos Cannabis
Ethos Cannabis is a multistate operator with operations in Pennsylvania, Massachusetts, and Ohio. Ethos boasts four brands in its portfolio, Natural Selections (MA & PA), Eleven (MA & PA), Headliners (MA), and Meigs County (OH). The platform serves mainstream consumers while expanding the health and wellness market through relationships with Thomas Jefferson University and other academic medical institutions and strategic partnerships.
Related Articles:
